Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 5 November 1993:
Vol. 262. no. 5135, pp. 900 - 902
DOI: 10.1126/science.8235612

Articles

Science, Vol 262, Issue 5135, 900-902
Copyright © 1993 by American Association for the Advancement of Science


articles

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin

R Ebner, RH Chen, S Lawler, T Zioncheck, and R Derynck

Departments of Growth and Development, and Anatomy, University of California at San Francisco 94143-0640.

Transforming growth factor-beta (TGF-beta) and activin signal primarily through interaction with type I and type II receptors, which are transmembrane serine-threonine kinases. Tsk 7L is a type I receptor for TGF-beta and requires coexpression of the type II TGF-beta receptor for ligand binding. Tsk 7L also specifically bound activin, when coexpressed with the type IIA activin receptor. Tsk 7L could associate with either type II receptor and the ligand binding specificity of Tsk 7L was conferred by the type II receptor. Tsk 7L can therefore act as type I receptor for both activin and TGF-beta, and possibly other ligands.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cancer-Associated Transforming Growth Factor {beta} Type II Receptor Gene Mutant Causes Activation of Bone Morphogenic Protein-Smads and Invasive Phenotype.
S. Bharathy, W. Xie, J. M. Yingling, and M. Reiss (2008)
Cancer Res. 68, 1656-1666
   Abstract »    Full Text »    PDF »
From The Cover: Dysregulation of TGF-{beta}1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice.
X. Wang, S. Inoue, J. Gu, E. Miyoshi, K. Noda, W. Li, Y. Mizuno-Horikawa, M. Nakano, M. Asahi, M. Takahashi, et al. (2005)
PNAS 102, 15791-15796
   Abstract »    Full Text »    PDF »
Change of Plasma Transforming Growth Factor-{beta}1 Levels in Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemo-radiotherapy.
H.-W. Chen, Y.-C. Chang, Y.-L. Lai, Y.-J. Chen, M.-J. Huang, Y.-S. Leu, Y.-K. Fu, L.-W. Wang, and J.-J. Hwang (2005)
Jpn. J. Clin. Oncol. 35, 427-432
   Abstract »    Full Text »    PDF »
Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice.
C. Schramm, M. Protschka, H. H. Kohler, J. Podlech, M. J. Reddehase, P. Schirmacher, P. R. Galle, A. W. Lohse, and M. Blessing (2003)
Am J Physiol Gastrointest Liver Physiol 284, G525-G535
   Abstract »    Full Text »    PDF »
TGF-{beta} Regulates Airway Responses Via T Cells.
C. Schramm, U. Herz, J. Podlech, M. Protschka, S. Finotto, M. J. Reddehase, H. Kohler, P. R. Galle, A. W. Lohse, and M. Blessing (2003)
J. Immunol. 170, 1313-1319
   Abstract »    Full Text »    PDF »
Regulation of ALK-1 Signaling by the Nuclear Receptor LXRbeta.
J. Mo, S. J. Fang, W. Chen, and G. C. Blobe (2002)
J. Biol. Chem. 277, 50788-50794
   Abstract »    Full Text »    PDF »
Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily.
H. Chang, C. W. Brown, and M. M. Matzuk (2002)
Endocr. Rev. 23, 787-823
   Abstract »    Full Text »    PDF »
Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.
Z. A. Quinn, C.-C. Yang, J. L. Wrana, and J. C. McDermott (2001)
Nucleic Acids Res. 29, 732-742
   Abstract »    Full Text »    PDF »
The type I serine/threonine kinase receptor Alk8/Lost-a-fin is required for Bmp2b/7 signal transduction during dorsoventral patterning of the zebrafish embryo.
H Bauer, Z Lele, G. Rauch, R Geisler, and M Hammerschmidt (2001)
Development 128, 849-858
   Abstract »    PDF »
Activin beta C and beta E Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration.
A. L. Lau, T. R. Kumar, K. Nishimori, J. Bonadio, and M. M. Matzuk (2000)
Mol. Cell. Biol. 20, 6127-6137
   Abstract »    Full Text »
Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.
K. Kitamura, S.-i. Aota, R. Sakamoto, S.-I. Yoshikawa, and K. Okazaki (2000)
Blood 95, 3371-3379
   Abstract »    Full Text »    PDF »
Activin A-Induced HepG2 Liver Cell Apoptosis: Involvement of Activin Receptors and Smad Proteins.
W. Chen, T. K. Woodruff, and K. E. Mayo (2000)
Endocrinology 141, 1263-1272
   Abstract »    Full Text »    PDF »
Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS.
P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al. (1999)
Clin. Cancer Res. 5, 3488-3499
   Abstract »    Full Text »    PDF »
Extracellular Domain of the Transforming Growth Factor-beta Receptor Negatively Regulates Ligand-independent Receptor Activation.
H.-J. Zhu and A. M. Sizeland (1999)
J. Biol. Chem. 274, 29220-29227
   Abstract »    Full Text »    PDF »
Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.
Q. Wang, Y. Wang, D. M Hyde, P. J Gotwals, V. E Koteliansky, S. T Ryan, and S. N Giri (1999)
Thorax 54, 805-812
   Abstract »    Full Text »
Activin and Inhibin Binding to the Soluble Extracellular Domain of Activin Receptor II.
C. J. Donaldson, J. M. Vaughan, A. Z. Corrigan, W. H. Fischer, and W. W. Vale (1999)
Endocrinology 140, 1760-1766
   Abstract »    Full Text »
Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-beta Family Receptors.
Y.-G. Chen and J. Massague (1999)
J. Biol. Chem. 274, 3672-3677
   Abstract »    Full Text »    PDF »
Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-beta Superfamily.
N. P. Barbara, J. L. Wrana, and M. Letarte (1999)
J. Biol. Chem. 274, 584-594
   Abstract »    Full Text »    PDF »
Control of digit formation by activin signalling.
R Merino, D Macias, Y Ganan, J Rodriguez-Leon, A. Economides, C Rodriguez-Esteban, J. Izpisua-Belmonte, and J. Hurle (1999)
Development 126, 2161-2170
   Abstract »    PDF »
Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling.
J.-J. Lebrun, K. Takabe, Y. Chen, and W. Vale (1999)
Mol. Endocrinol. 13, 15-23
   Abstract »    Full Text »
Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells.
A. Ishisaki, K. Yamato, A. Nakao, K. Nonaka, M. Ohguchi, P. ten Dijke, and T. Nishihara (1998)
J. Biol. Chem. 273, 24293-24296
   Abstract »    Full Text »    PDF »
The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse.
Z. Gu, M. Nomura, B. B. Simpson, H. Lei, A. Feijen, J. van den Eijnden-van Raaij, P. K. Donahoe, and E. Li (1998)
Genes & Dev. 12, 844-857
   Abstract »    Full Text »
Smad8 mediates the signaling of the receptor serine kinase.
Y. Chen, A. Bhushan, and W. Vale (1997)
PNAS 94, 12938-12943
   Abstract »    Full Text »    PDF »
Function of the Type V Transforming Growth Factor beta  Receptor in Transforming Growth Factor beta -induced Growth Inhibition of Mink Lung Epithelial Cells.
Q. Liu, S. S. Huang, and J. S. Huang (1997)
J. Biol. Chem. 272, 18891-18895
   Abstract »    Full Text »    PDF »
The Type II Transforming Growth Factor-beta Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues.
S. Lawler, X.-H. Feng, R.-H. Chen, E. M. Maruoka, C. W. Turck, I. Griswold-Prenner, and R. Derynck (1997)
J. Biol. Chem. 272, 14850-14859
   Abstract »    Full Text »    PDF »
Bovine Activin Receptor Type IIB Messenger Ribonucleic Acid Displays Alternative Splicing Involving a Sequence Homologous to Src-Homology 3 domain Binding Sites.
J.-F. Ethier, J. G. Lussier, and D. W. Silversides (1997)
Endocrinology 138, 2425-2434
   Abstract »    Full Text »    PDF »
Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5.
H. Nishitoh, H. Ichijo, M. Kimura, T. Matsumoto, F. Makishima, A. Yamaguchi, H. Yamashita, S. Enomoto, and K. Miyazono (1996)
J. Biol. Chem. 271, 21345-21352
   Abstract »    Full Text »    PDF »
Ligand-independent Activation of Transforming Growth Factor (TGF) beta Signaling Pathways by Heteromeric Cytoplasmic Domains of TGF-beta Receptors.
X.-H. Feng and R. Derynck (1996)
J. Biol. Chem. 271, 13123-13129
   Abstract »    Full Text »    PDF »
Identification of Important Regions in the Cytoplasmic Juxtamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-beta.
M. Saitoh, H. Nishitoh, T. Amagasa, K. Miyazono, M. Takagi, and H. Ichijo (1996)
J. Biol. Chem. 271, 2769-2775
   Abstract »    Full Text »    PDF »
Interaction of the Transforming Growth Factor-beta Type I Receptor with Farnesyl-protein Transferase-alpha.
M. Kawabata, T. Imamura, K. Miyazono, M. E. Engel, and H. L. Moses (1995)
J. Biol. Chem. 270, 29628-29631
   Abstract »    Full Text »    PDF »
Transforming Growth Factor-beta (TGF-beta)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-beta Receptor Complex.
X.-H. Feng, E. H. Filvaroff, and R. Derynck (1995)
J. Biol. Chem. 270, 24237-24245
   Abstract »    Full Text »    PDF »
Identification of a Human Type II Receptor for Bone Morphogenetic Protein-4 That Forms Differential Heteromeric Complexes with Bone Morphogenetic Protein Type I Receptors.
T. Nohno, T. Ishikawa, T. Saito, K. Hosokawa, S. Noji, D. H. Wolsing, and J. S. Rosenbaum (1995)
J. Biol. Chem. 270, 22522-22526
   Abstract »    Full Text »    PDF »
Demonstration That Mutation of the Type II Transforming Growth Factor beta Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells.
J. Wang, L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J. K. V. Willson, et al. (1995)
J. Biol. Chem. 270, 22044-22049
   Abstract »    Full Text »    PDF »
Cooperative Binding of Transforming Growth Factor (TGF)-[IMAGE]2 to the Types I and II TGF-[IMAGE] Receptors.
C. Rodriguez, F. Chen, R. A. Weinberg, and H. F. Lodish (1995)
J. Biol. Chem. 270, 15919-15922
   Abstract »    Full Text »    PDF »
Phosphorylation-dependent Interaction of the Cytoplasmic Domains of the Type I and Type II Transforming Growth Factor-[IMAGE] Receptors.
R.-H. Chen, H. L. Moses, E. M. Maruoka, R. Derynck, and M. Kawabata (1995)
J. Biol. Chem. 270, 12235-12241
   Abstract »    Full Text »    PDF »
Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription.
T. Brand and M. D. Schneider (1995)
J. Biol. Chem. 270, 8274-8284
   Abstract »    Full Text »    PDF »
Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism.
J. Xu, K. McKeehan, K. Matsuzaki, and W. L. McKeehan (1995)
J. Biol. Chem. 270, 6308-6313
   Abstract »    Full Text »    PDF »
Cloning of a Novel Type II Serine/Threonine Kinase Receptor through Interaction with the Type I Transforming Growth Factor-beta Receptor.
M. Kawabata, A. Chytil, and H. L. Moses (1995)
J. Biol. Chem. 270, 5625-5630
   Abstract »    Full Text »    PDF »
The Soluble Exoplasmic Domain of the Type II Transforming Growth Factor (TGF)-beta Receptor.
H. Y. Lin, A. Moustakas, P. Knaus, R. G. Wells, Y. I. Henis, and H. F. Lodish (1995)
J. Biol. Chem. 270, 2747-2754
   Abstract »    Full Text »    PDF »
GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A.
A. Moustakas, T. Takumi, H. Y. Lin, and H. F. Lodish (1995)
J. Biol. Chem. 270, 765-769
   Abstract »    Full Text »    PDF »
Transforming Growth Factor {beta} in Tissue Fibrosis.
W. A. Border and N. A. Noble (1994)
N. Engl. J. Med. 331, 1286-1292
   Full Text »
Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12.
T Wang, P. Donahoe, and A. Zervos (1994)
Science 265, 674-676
   Abstract »    PDF »
Characterization of type I receptors for transforming growth factor-beta and activin.
P ten Dijke, H Yamashita, H Ichijo, P Franzen, M Laiho, K Miyazono, and C. Heldin (1994)
Science 264, 101-104
   Abstract »    PDF »
The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-beta superfamily.
T Xie, A. Finelli, and R. Padgett (1994)
Science 263, 1756-1759
   Abstract »    PDF »
The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms..
D M Kingsley (1994)
Genes & Dev. 8, 133-146
   PDF »
Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins.
A Feijen, M. Goumans, and A. van den Eijnden-van Raaij (1994)
Development 120, 3621-3637
   Abstract »    PDF »
A transforming growth factor beta type I receptor that signals to activate gene expression.
C. Bassing, J. Yingling, D. Howe, T Wang, W. He, M. Gustafson, P Shah, P. Donahoe, and X. Wang (1994)
Science 263, 87-89
   Abstract »    PDF »
Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.
E. Filvaroff, R Ebner, and R Derynck (1994)
Development 120, 1085-1095
   Abstract »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)